2-[(4R)-4-Hydroxy-2-oxo-1-pyrrolidinyl]acetamide structure
|
Common Name | 2-[(4R)-4-Hydroxy-2-oxo-1-pyrrolidinyl]acetamide | ||
---|---|---|---|---|
CAS Number | 88929-35-5 | Molecular Weight | 158.16 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 494.6±40.0 °C at 760 mmHg | |
Molecular Formula | C6H10N2O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 252.9±27.3 °C |
Use of 2-[(4R)-4-Hydroxy-2-oxo-1-pyrrolidinyl]acetamide(S)-oxiracetam (S-ORC) is an inhibitor targeting apoptosis. S-ORC reduces brain infarct size and lessens neurological dysfunction in middle cerebral artery occlusion/reperfusion (MCAO/R) models. S-ORC prevents neuronal apoptosis via activating PI3K/Akt/GSK3β signaling pathway via α7 nAChR after ischemic stroke. S-ORC can prevent neuronal death after ischemic stroke[1]. |
Name | 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (4S) |
---|---|
Synonym | More Synonyms |
Description | (S)-oxiracetam (S-ORC) is an inhibitor targeting apoptosis. S-ORC reduces brain infarct size and lessens neurological dysfunction in middle cerebral artery occlusion/reperfusion (MCAO/R) models. S-ORC prevents neuronal apoptosis via activating PI3K/Akt/GSK3β signaling pathway via α7 nAChR after ischemic stroke. S-ORC can prevent neuronal death after ischemic stroke[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 494.6±40.0 °C at 760 mmHg |
Molecular Formula | C6H10N2O3 |
Molecular Weight | 158.16 |
Flash Point | 252.9±27.3 °C |
Exact Mass | 158.069138 |
PSA | 83.63000 |
LogP | -2.48 |
Vapour Pressure | 0.0±2.9 mmHg at 25°C |
Index of Refraction | 1.570 |
1-PYRROLIDINEACETAMIDE,4-HYDROXY-2-OXO-, (4S)- |
(S)-2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide |
2-[(4S)-4-hydroxy-2-oxopyrrolidin-1-yl]acetamide |
S-(-)-Oxiracetam |
oxiracetam |
1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (S)- |
(S)-Oxiracetam |
2-[(4R)-4-Hydroxy-2-oxo-1-pyrrolidinyl]acetamide |
(S)-4-Hydroxy-2-oxo-1-pyrrolidineacetamide |
1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (4R)- |